This is a working overview of GHS-R1a, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-12-17 and is reviewed periodically as new material appears.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, a structure that differs from natural ghrelin in length and in the presence of non-natural amino acid residues. Early laboratory work described it as a comparatively selective agent that stimulates growth hormone release with limited effect on other pituitary hormones. The compound is supplied as a lyophilized solid for research use and has no identified natural source in the body.
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
Published animal and early human work describes growth hormone release that is separated from comparable rises in adrenocorticotropic hormone and cortisol. Prolactin changes are reported as small in the same studies. Selectivity is attributed to binding at the ghrelin receptor and to the downstream signaling that follows, rather than to differences in how quickly the peptide is cleared. Authors commonly label the compound selective rather than potent, because the same mass produces a smaller growth hormone response than some older secretagogues tested in parallel. Whether that profile holds across species and routes of administration remains an open question.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class. It acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. The compound was designed in the 1990s during a search for agents that release growth hormone with fewer off-target hormonal effects than earlier secretagogues. It appears in the research literature under several sequence-based names. Material supplied for laboratory work is normally a lyophilized solid, and it is not marketed as an approved therapeutic in major jurisdictions.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic pentapeptide | GHS-R1a agonist family |
| Receptor target | Ghrelin receptor (GHS-R1a) | G-protein-coupled receptor |
| Sequence length | Five amino acid residues | Includes non-natural residues |
| Primary reported output | Pulsatile growth hormone release | Observed in animal and early human work |
| Molecular formula | C38H49N9O5 | Corresponds to roughly 711.9 g/mol |
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
Identity and purity are assessed by complementary methods rather than a single test. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and reports a percentage purity. Mass spectrometry, most often with electrospray ionization, confirms the expected molecular mass and detects sequence-related variants. Amino acid analysis can verify composition, while water content and residual counterion measurements support the mass balance of a batch. Stability studies under accelerated conditions are used to estimate shelf life, though such estimates carry uncertainty for long-term storage.
对 ipamorelin 的常规表征以反相高效液相色谱测定纯度，检测波长多设为 214 nm，因为肽键在该波长有较强吸收。身份确认通常借助电喷雾电离质谱或串联质谱，将实测分子量与理论值逐项比对。序列层面可用肽图分析或氨基酸分析进一步验证。这些手段组合起来，可以分别覆盖纯度、身份与序列三个不同层次的信息。
杂质谱一般包含缺失序列片段、差向异构体、氧化产物以及残留溶剂或反离子，其中组氨酸与芳香残基的氧化常被重点关注。反相色谱中这类杂质往往紧邻主峰洗脱，因此方法需要足够的分离度并经过系统适用性验证。纯度百分比的解读依赖于检测波长与梯度条件，不同实验室公布的数字不宜直接横向比较。参考标准品有助于跨批次对照，但其自身赋值同样需要可追溯来源。
Greenland Prime Minister Jens-Frederik Nielsen called the deal "gratifying" and "for the benefit of us all." On 22 September 2026, during the general debate of the eighty-first session of the United Nations General Assembly, the United States, Denmark, and Greenland signed a security agreement that increases US involvement in Greenland's defence while affirming Danish sovereignty and Greenland's right to self-determination.
== Etymology == The nomenclature for the Do6a venom peptide splits into two components: "Do" refers to the specific Velvet ant species it is extracted from: the Dasymutilla occidentalis. "6a" refers to the specific family and isoform of the Do peptide. Other venom peptides originating from different velvet ant species exist that follow similar nomenclature, such as Dk5a in Dasymutilla klugii.
== Promotional sponsorship == Major League Soccer team Real Salt Lake announced on October 29, 2013, that it had partnered with LifeVantage for a long-term, multimillion-dollar jersey-front sponsorship. The partnership was set to formally go into effect on January 1, 2014, with the LifeVantage logo appearing on the Real Salt Lake jersey starting in the next season. In July 2015, Real Salt Lake owner Dell Loy Hansen was reported by the U.S. Securities and Exchange Commission to have bought a 5.1 percent ownership stake in LifeVantage.
=== Budget and taxes === In May 2025, Kiggans voted for the One Big Beautiful Bill Act. Kiggans advocated to maintain appropriated funds for NASA's Wallops Flight Facility and Langley Research Center in the 2026 federal budget. She argues that these locations are "prized possession for the Commonwealth" and that "the work that's going on there from the defense side, but also on the private industry side, [...] with places like Rocket Lab and Firefly, and Northrop Grumman is there."
Alkaloids containing a pyridine unit (pyridine alkaloids) occur frequently in insects, amphibians, and marine animals, as well as widely in plants. Many representatives occur in Virginian tobacco (Nicotiana tabacum). These include the principal alkaloid nicotine, as well as nornicotine, anabasine, and anatabine. Other compounds of this group are found in cordworms. Anabaseine occurs in the genus Paranemertes. In Amphiporus angulatus, 2,3'-bipyridine is found, as well as the main component nemertelline, which consists of four pyridine units. Pyridine alkaloids also occur in the genus fire ants (Solenopsis), including the red fire ant (Solenopsis invicta). These include, for example, 2-methyl-6-undecylpyridine and 2-methyl-6-tridecylpyridine, as well as related compounds with unsaturated side chains. The venom in the skin of the three-striped treehopper (Epipedobates tricolor) contains the pyridine alkaloid epibatidine.
Sources: en.wikipedia.org
Ionisation isomerism – the isomers give different ions in solution although they have the same composition. This type of isomerism occurs when the counter ion of the complex is also a potential ligand. For example, pentaamminebromocobalt(III) sulphate [Co(NH3)5Br]SO4 is red violet and in solution gives a precipitate with barium chloride, confirming the presence of sulphate ion, while pentaamminesulphatecobalt(III) bromide [Co(NH3)5SO4]Br is red and tests negative for sulphate ion in solution, but instead gives a precipitate of AgBr with silver nitrate. Solvate or hydrate isomerism – the isomers have the same composition but differ with respect to the number of molecules of solvent that serve as ligand vs simply occupying sites in the crystal. Examples: [Cr(H2O)6]Cl3 is violet colored, [CrCl(H2O)5]Cl2·H2O is blue-green, and [CrCl2(H2O)4]Cl·2H2O is dark green. See water of crystallization. Coordination isomerism occurs when both positive and negative ions of a salt are complex ions and the two isomers differ in the distribution of ligands between the cation and the anion. For example, [Co(NH3)6][Cr(CN)6] and [Cr(NH3)6][Co(CN)6].
== Mitchell Report == He was named in the Mitchell Report on Steroid Abuse in Baseball on December 13, 2007. According to the report, Bigbie admitted to purchasing and using a variety of performance-enhancing substances from Kirk Radomski from 2001 to 2005, including human growth hormone, Deca-Durabolin, Sustanon, testosterone, and anti-estrogen drugs. Bigbie was introduced to Radomski through former teammate David Segui. Segui reportedly instructed him on "training regimens and the use of creatine, a legal muscle builder, before teaching him about steroids and eventually injecting him with Deca-Durabolin". After he started using steroids, Bigbie gained 30 pounds while maintaining a body fat percentage of 7%.
== Sources == Magurno, B. A.; Pearlstein, S., eds. (1981). Proceedings of the conference on nuclear data evaluation methods and procedures. BNL-NCS 51363 (PDF). Vol. II. Upton: Brookhaven National Laboratory. Archived (PDF) from the original on March 8, 2021. Retrieved August 6, 2014. Miner, William N.; Schonfeld, Fred W. (1968). "Plutonium". In Clifford A. Hampel (ed.). The Encyclopedia of the Chemical Elements. New York (NY): Reinhold Book Corporation. pp. 540–546. LCCN 68029938.
=== Agriculture and food === Characterization of plant root exometabolites to determine how exometabolites affect Plant-growth promoting rhizobacteria. Metabolic footprinting of yeast strains for identification of yeast strains optimal for enhancing fermentation performance and positive attributes in wine.
Sources: en.wikipedia.org
Capillary action (sometimes called capillarity, capillary motion, capillary rise, capillary effect, or wicking) is the process of a liquid flowing in a narrow space without the assistance of external forces like gravity. The effect can be seen in the drawing up of liquids between the hairs of a paint brush, in a thin tube such as a straw, in porous materials such as paper and plaster, in some non-porous materials such as clay and liquefied carbon fiber, or in biological cells. It occurs because of intermolecular forces between the liquid and surrounding solid surfaces. If the diameter of the tube is sufficiently small, then the combination of surface tension (which is caused by cohesion within the liquid) and adhesive forces between the liquid and container wall act to propel the liquid.
In October 2017, Whirlpool and Sears Holding Corp. ended their 101-year partnership, which had allowed Whirlpool-branded appliances to be sold at Sears and Kmart stores, due to unresolved pricing negotiations. Whirlpool continues to manufacture Kenmore appliances for Sears. In March 2020, Whirlpool Corporation announced the official opening of a new Factory Distribution Center in Tulsa, Oklahoma. In November 2022, Whirlpool acquired the Wisconsin-based garbage disposal manufacturer InSinkErator.
Molecular: HCHO + hν → H2 + CO (λ < 360 nm) Radical: HCHO + hν → H + HCO (λ < 330 nm) The H and HCO radicals react with the atmospheric O2 to form hydroperoxyl (HO2) radicals, giving a net radical channel of:
Sources: en.wikipedia.org
It is a synthetic pentapeptide in the growth hormone secretagogue family and acts as an agonist at the ghrelin receptor. It is handled as a laboratory research compound rather than a naturally occurring hormone.
Studies generally report growth hormone as the dominant output, with smaller or absent effects on adrenocorticotropic hormone and prolactin. The size of that separation depends on the assay and the dose examined, so it is best described as relative selectivity.
No natural source has been identified, and the molecule is produced by chemical synthesis. Its non-natural residues distinguish it from endogenous ghrelin even though both engage the same receptor.
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.